Thrombosis and neointimal hyperplasia limit the utility of small-caliber ar
tificial vascular grafts. Surface modifications and adjunctive pharmacologi
cal therapy might mediate these complications. We examined the mechanisms b
y which a model vasoactive compound, heparin, transverses porous graft mate
rials and how material modifications alters this drug's transport. The effe
ctive permeance of [H-3]heparin was measured after application of a uniform
concentration of drug to either the internal or external surface of the gr
aft and in the presence or absence of pressure-driven physiologic hydraulic
flows. Transgraft permeance was equivalent to these observed in normal art
eries and, while enhanced by convection, was mediated in major part by diff
usion. Peclet numbers under the Various conditions examined ranged from 0.0
5. to 1.2, indicating that diffusive forces were equal to or exceeded conve
ctive forces in governing transmural heparin motion. Heparin traversed the
graft even when applied from the outer perivascular surface, against advers
e hydraulic flows. Modifications of the grafts that included a yam barrier
of spun poly(tetrafluoroethylene) or chemical modification of surface tensi
on energy altered permeances as well. A unifying model for interpretation o
f these data incorporates the concept of entrapped air and surface tension
energy in the graft. These characterizations allow for the design of vascul
ar grafts that are optimized for pharmacotherapy to help prolong graft pate
ncy,especially in small-caliber vascular beds. (C) 2000 John Wiley & Sons,
Inc.